Fractyl Health (GUTS) Convertible Debt (2023 - 2025)
Fractyl Health's (GUTS) quarterly Convertible Debt came in at $20.9 million in Q4 2025, little changed YoY from $20.9 million in Q4 2024, and little changed on a QoQ basis from $20.9 million in Q3 2025.
Fractyl Health (GUTS) Convertible Debt (2023 - 2025) Analysis & Trends
Fractyl Health (GUTS) has 3 years of Convertible Debt data on file, last reported at $20.9 million in Q4 2025.
- Quarterly Convertible Debt changed 0.0% year-over-year to $20.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $20.9 million, changed 0.0% from the prior year.
- Convertible Debt was little changed at $20.9 million in Q4 2025, from $20.9 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $27.2 million in Q4 2023 to a low of $20.9 million in Q1 2024.
- A 3-year average of $21.6 million and a median of $20.9 million in 2025 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2024 — Convertible Debt fell 23.06% — and 2025, when it gained 0.0%.
- Tracing GUTS's Convertible Debt over 3 years: stood at $27.2 million in 2023, then slipped by 23.06% to $20.9 million in 2024, then advanced by 0.0% to $20.9 million in 2025.
- The last three Convertible Debt figures came in at $20.9 million (Q4 2025), $20.9 million (Q3 2025), and $20.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.20 Bn | 131.35 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.09 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.04 Bn | 9.65 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.50 Bn | - |
| 10 | Fractyl Health | 125.68 Mn | 125.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 20.90 Mn |
| Jun 30, 2025 | 20.90 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | 20.90 Mn |
| Sep 30, 2024 | 20.90 Mn |
| Jun 30, 2024 | 20.90 Mn |
| Mar 31, 2024 | 20.90 Mn |
| Dec 31, 2023 | 27.16 Mn |